SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007860
Filing Date
2024-05-13
Accepted
2024-05-13 06:59:32
Documents
59
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mist-20240331x10q.htm   iXBRL 10-Q 1229355
2 EX-10.1 mist-20240331xex10d1.htm EX-10.1 19274
3 EX-31.1 mist-20240331xex31d1.htm EX-31.1 12312
4 EX-31.2 mist-20240331xex31d2.htm EX-31.2 12463
5 EX-32.1 mist-20240331xex32d1.htm EX-32.1 9433
  Complete submission text file 0001558370-24-007860.txt   5579723

Data Files

Seq Description Document Type Size
6 EX-101.SCH mist-20240331.xsd EX-101.SCH 39285
7 EX-101.CAL mist-20240331_cal.xml EX-101.CAL 38145
8 EX-101.DEF mist-20240331_def.xml EX-101.DEF 154222
9 EX-101.LAB mist-20240331_lab.xml EX-101.LAB 348053
10 EX-101.PRE mist-20240331_pre.xml EX-101.PRE 266292
63 EXTRACTED XBRL INSTANCE DOCUMENT mist-20240331x10q_htm.xml XML 1033598
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38899 | Film No.: 24936822
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)